-
aca replied to the topic "PM Problem Involving Pre-clinical Trial Results and Market Entry Deadlines" – 2 months, 4 weeks ago
A new concept that can be discussed is design controls and regulatory documentation and traceability when animal data affects the product’s timeline. In a Class III medical device like the bio-absorbable stent, since the dissolution rate can be directly caused… Read more»